Document is current
Any future updates will be listed below
-
Authors
Moser, Manuel
Adl Amini, Dominik
Albertini Sanchez, Leonardo
Oezel, Lisa
Haffer, Henryk
Muellner, Maximilian
Zhu, Jiaqi
Carrino, John A.
Shue, Jennifer
Sama, Andrew A.
Cammisa, Frank P.
Girardi, Federico P.
Hughes, Alexander P. https://orcid.org/0000-0001-7293-9672
- License Information
-
More Information
Article History
Received: 22 October 2022
Revised: 22 October 2022
Accepted: 13 January 2023
First Online: 11 February 2023
Declarations
:
: Authors DAA, LAS, LO, HH, MM, JZ, and JS have no relevant financial or non-financial interests to disclose. Author MM declares financial interests: Research Support: Medtronic (Schweiz) AG. Author JAC declares financial interests: Consulting: Pfizer, Inc.; Eli-Lilly; Globus Medical; Regeneron; AstraZeneca; Scientific Advisory Board: Carestream; Image Analysis Group; Image Biopsy Lab. Author AAS declares financial interests: Royalties: Ortho Development Corp. Private Investments: Vestia Ventures MiRus Investment, LLC; ISPH II, LLC; ISPH 3, LLC; VBros Venture Partners X; Centinel Spine. Consulting: Clariance, Inc.; Kuros Biosciences AG, DePuy Synthes Products, Inc./Medical Device Business Services, Inc. Speaking and/or Teaching Arrangements: DePuy Synthes Products, Inc./Medical Device Business Services, Inc. Scientific Advisory Board: DePuy Synthes Products, Inc./Medical Device Business Services, Inc. Research Support: Spinal Kinetics, Inc. Author FPC declares financial interests: Research Support: 4WEB Medical Inc.; Camber Spine, Centinel Spine; Mallinckrodt Pharmaceuticals. Consulting: Accelus, NuVasive, Inc.; Spine Biopharma, LLC. Royalties: Accelus. Ownership Interest: Healthpoint Capital Partners, LP; ISPH II, LLC; ISPH 3 Holdings, LLC; Ivy Healthcare Capital Partners, LLC; Medical Device Partners II, LLC; Medical Device Partners III, LLC; Tissue Differentiation Intelligence, LLC; VBVP VI, LLC; VBVP X, LLC; Woven Orthopedic Technologies. Board of Directors: Orthobond Corporation; Medical Device Partners II, LLC; Spine Biopharma, LLC; Woven Orthopedic Technologies. Author FPG declares financial interests: Consulting: DePuy Synthes Spine; NuVasive, Inc.; Spineart USA, Inc.; Ethicon, Inc.; Ortho Development Corp. Stock/Shareholder: Bonovo Orthopedics, Inc.; Healthpoint Capital Partners, LP; Tissue Differentiation Intelligence; BICMD. Royalties: NuVasive, Inc.; Ortho Development Corp; DePuy Synthes Spine. Author APH declares financial interests: Research Support: Kuros Biosciences AG. Fellowship Support: Kuros Biosurgery AG, NuVasive, Inc.
: IRB approval: Hospital for Special Surgery #2019–2137.
